Eintrag weiter verarbeiten
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Gespeichert in:
| Zeitschriftentitel: | CA: A Cancer Journal for Clinicians |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , |
| In: | CA: A Cancer Journal for Clinicians, 69, 2019, 4, S. 305-343 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
El‐Deiry, Wafik S. Goldberg, Richard M. Lenz, Heinz‐Josef Shields, Anthony F. Gibney, Geoffrey T. Tan, Antoinette R. Brown, Jubilee Eisenberg, Burton Heath, Elisabeth I. Phuphanich, Surasak Kim, Edward Brenner, Andrew J. Marshall, John L. El‐Deiry, Wafik S. Goldberg, Richard M. Lenz, Heinz‐Josef Shields, Anthony F. Gibney, Geoffrey T. Tan, Antoinette R. Brown, Jubilee Eisenberg, Burton Heath, Elisabeth I. Phuphanich, Surasak Kim, Edward Brenner, Andrew J. Marshall, John L. |
|---|---|
| author |
El‐Deiry, Wafik S. Goldberg, Richard M. Lenz, Heinz‐Josef Shields, Anthony F. Gibney, Geoffrey T. Tan, Antoinette R. Brown, Jubilee Eisenberg, Burton Heath, Elisabeth I. Phuphanich, Surasak Kim, Edward Brenner, Andrew J. Marshall, John L. |
| spellingShingle |
El‐Deiry, Wafik S. Goldberg, Richard M. Lenz, Heinz‐Josef Shields, Anthony F. Gibney, Geoffrey T. Tan, Antoinette R. Brown, Jubilee Eisenberg, Burton Heath, Elisabeth I. Phuphanich, Surasak Kim, Edward Brenner, Andrew J. Marshall, John L. CA: A Cancer Journal for Clinicians The current state of molecular testing in the treatment of patients with solid tumors, 2019 Oncology Hematology |
| author_sort |
el‐deiry, wafik s. |
| spelling |
El‐Deiry, Wafik S. Goldberg, Richard M. Lenz, Heinz‐Josef Shields, Anthony F. Gibney, Geoffrey T. Tan, Antoinette R. Brown, Jubilee Eisenberg, Burton Heath, Elisabeth I. Phuphanich, Surasak Kim, Edward Brenner, Andrew J. Marshall, John L. 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21560 <jats:title>Abstract</jats:title><jats:p>The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical practice have evolved. Broad molecular profiling is now nearly essential for all patients with metastatic solid tumors. New agents have been approved based on molecular testing instead of tumor site of origin. Molecular profiling methodologies have likewise changed such that tests that were performed on patients a few years ago are no longer complete and possibly inaccurate today. As with all rapid change, medical providers can quickly fall behind or struggle to find up‐to‐date sources to ensure he or she provides optimum care. In this review, the authors provide the current state of the art for molecular profiling/precision medicine, practice standards, and a view into the future ahead.</jats:p> The current state of molecular testing in the treatment of patients with solid tumors, 2019 CA: A Cancer Journal for Clinicians |
| doi_str_mv |
10.3322/caac.21560 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTYw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTYw |
| institution |
DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 |
| imprint |
Wiley, 2019 |
| imprint_str_mv |
Wiley, 2019 |
| issn |
0007-9235 1542-4863 |
| issn_str_mv |
0007-9235 1542-4863 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
eldeiry2019thecurrentstateofmoleculartestinginthetreatmentofpatientswithsolidtumors2019 |
| publishDateSort |
2019 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
CA: A Cancer Journal for Clinicians |
| source_id |
49 |
| title |
The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_unstemmed |
The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_full |
The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_fullStr |
The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_full_unstemmed |
The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_short |
The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_sort |
the current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| topic |
Oncology Hematology |
| url |
http://dx.doi.org/10.3322/caac.21560 |
| publishDate |
2019 |
| physical |
305-343 |
| description |
<jats:title>Abstract</jats:title><jats:p>The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical practice have evolved. Broad molecular profiling is now nearly essential for all patients with metastatic solid tumors. New agents have been approved based on molecular testing instead of tumor site of origin. Molecular profiling methodologies have likewise changed such that tests that were performed on patients a few years ago are no longer complete and possibly inaccurate today. As with all rapid change, medical providers can quickly fall behind or struggle to find up‐to‐date sources to ensure he or she provides optimum care. In this review, the authors provide the current state of the art for molecular profiling/precision medicine, practice standards, and a view into the future ahead.</jats:p> |
| container_issue |
4 |
| container_start_page |
305 |
| container_title |
CA: A Cancer Journal for Clinicians |
| container_volume |
69 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792346162391416839 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:34:58.94Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+current+state+of+molecular+testing+in+the+treatment+of+patients+with+solid+tumors%2C+2019&rft.date=2019-07-01&genre=article&issn=1542-4863&volume=69&issue=4&spage=305&epage=343&pages=305-343&jtitle=CA%3A+A+Cancer+Journal+for+Clinicians&atitle=The+current+state+of+molecular+testing+in+the+treatment+of+patients+with+solid+tumors%2C+2019&aulast=Marshall&aufirst=John+L.&rft_id=info%3Adoi%2F10.3322%2Fcaac.21560&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792346162391416839 |
| author | El‐Deiry, Wafik S., Goldberg, Richard M., Lenz, Heinz‐Josef, Shields, Anthony F., Gibney, Geoffrey T., Tan, Antoinette R., Brown, Jubilee, Eisenberg, Burton, Heath, Elisabeth I., Phuphanich, Surasak, Kim, Edward, Brenner, Andrew J., Marshall, John L. |
| author_facet | El‐Deiry, Wafik S., Goldberg, Richard M., Lenz, Heinz‐Josef, Shields, Anthony F., Gibney, Geoffrey T., Tan, Antoinette R., Brown, Jubilee, Eisenberg, Burton, Heath, Elisabeth I., Phuphanich, Surasak, Kim, Edward, Brenner, Andrew J., Marshall, John L., El‐Deiry, Wafik S., Goldberg, Richard M., Lenz, Heinz‐Josef, Shields, Anthony F., Gibney, Geoffrey T., Tan, Antoinette R., Brown, Jubilee, Eisenberg, Burton, Heath, Elisabeth I., Phuphanich, Surasak, Kim, Edward, Brenner, Andrew J., Marshall, John L. |
| author_sort | el‐deiry, wafik s. |
| container_issue | 4 |
| container_start_page | 305 |
| container_title | CA: A Cancer Journal for Clinicians |
| container_volume | 69 |
| description | <jats:title>Abstract</jats:title><jats:p>The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical practice have evolved. Broad molecular profiling is now nearly essential for all patients with metastatic solid tumors. New agents have been approved based on molecular testing instead of tumor site of origin. Molecular profiling methodologies have likewise changed such that tests that were performed on patients a few years ago are no longer complete and possibly inaccurate today. As with all rapid change, medical providers can quickly fall behind or struggle to find up‐to‐date sources to ensure he or she provides optimum care. In this review, the authors provide the current state of the art for molecular profiling/precision medicine, practice standards, and a view into the future ahead.</jats:p> |
| doi_str_mv | 10.3322/caac.21560 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTYw |
| imprint | Wiley, 2019 |
| imprint_str_mv | Wiley, 2019 |
| institution | DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14 |
| issn | 0007-9235, 1542-4863 |
| issn_str_mv | 0007-9235, 1542-4863 |
| language | English |
| last_indexed | 2024-03-01T17:34:58.94Z |
| match_str | eldeiry2019thecurrentstateofmoleculartestinginthetreatmentofpatientswithsolidtumors2019 |
| mega_collection | Wiley (CrossRef) |
| physical | 305-343 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | CA: A Cancer Journal for Clinicians |
| source_id | 49 |
| spelling | El‐Deiry, Wafik S. Goldberg, Richard M. Lenz, Heinz‐Josef Shields, Anthony F. Gibney, Geoffrey T. Tan, Antoinette R. Brown, Jubilee Eisenberg, Burton Heath, Elisabeth I. Phuphanich, Surasak Kim, Edward Brenner, Andrew J. Marshall, John L. 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21560 <jats:title>Abstract</jats:title><jats:p>The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical practice have evolved. Broad molecular profiling is now nearly essential for all patients with metastatic solid tumors. New agents have been approved based on molecular testing instead of tumor site of origin. Molecular profiling methodologies have likewise changed such that tests that were performed on patients a few years ago are no longer complete and possibly inaccurate today. As with all rapid change, medical providers can quickly fall behind or struggle to find up‐to‐date sources to ensure he or she provides optimum care. In this review, the authors provide the current state of the art for molecular profiling/precision medicine, practice standards, and a view into the future ahead.</jats:p> The current state of molecular testing in the treatment of patients with solid tumors, 2019 CA: A Cancer Journal for Clinicians |
| spellingShingle | El‐Deiry, Wafik S., Goldberg, Richard M., Lenz, Heinz‐Josef, Shields, Anthony F., Gibney, Geoffrey T., Tan, Antoinette R., Brown, Jubilee, Eisenberg, Burton, Heath, Elisabeth I., Phuphanich, Surasak, Kim, Edward, Brenner, Andrew J., Marshall, John L., CA: A Cancer Journal for Clinicians, The current state of molecular testing in the treatment of patients with solid tumors, 2019, Oncology, Hematology |
| title | The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_full | The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_fullStr | The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_full_unstemmed | The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_short | The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_sort | the current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| title_unstemmed | The current state of molecular testing in the treatment of patients with solid tumors, 2019 |
| topic | Oncology, Hematology |
| url | http://dx.doi.org/10.3322/caac.21560 |